Risk profile tool provides clearer insight on hospitalized COVID-19 patients who benefit most from baricitinib treatment
Credit: CC0 Public Domain A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk…
Bringing News as it Unfolds
Credit: CC0 Public Domain A post-hoc analysis of ACTT-2 (Adaptive COVID-19 Treatment Trial-2) found that the use of a risk…